News

Tufts Health Plan, Harvard Pilgrim owner to limit coverage of weight-loss drugs
Point32Health will dramatically change how and when it pays for Zepbound — the insurer’s preferred GLP-1 weight-loss drug— ...
Psychology Today3h
Is Stress Sabotaging Your Weight Loss Journey?
The strategy of rewiring the brain's stress response is rooted in two pieces of scientific literature. One is biochemical.
Patients Are Left With Few Options as GLP-1 Copycats Disappear
With the active ingredients in drugs like Ozempic and Zepbound no longer in shortage, access to medicine for millions who had ...
Novo Nordisk Rises on Weight-Loss News. It’s a Huge Deal for This Stock.
The Ozempic maker and its peers are setting their sights on oral obesity medications to diversify their portfolios and remain ...
First-Generation GLP-1 Drugs May Help Lower Risk of Obesity-Related Cancers
First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...
Weight loss drugs have "no end game" amid lack of data on long-term use, former FDA commissioner warns
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Rolling Out1d
Weight-loss injections slash cancer risk
Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...
Lose It! on MSN8h
Can Microdosing a GLP-1 Medication Help You Lose Weight?
In fact, you may have gotten more than a few targeted ads on social media from telehealth platforms selling these cheaper GLP ...